Showing results (221-230 of 369) with videos related to

Sort By:
Pageof 37
Plos One|November 3, 2018
Awareness, prevalence, treatment, and control of type 2 diabetes in a semi-urban area of Nepal: Findings from a cross-sectional study conducted as a part of COBIN-D trialBishal Gyawali, Martin Rune Hassan Hansen, Mia Buhl Povlsen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 5, 2024
Common Sense (Radiation) Oncology: Redefining targets in radiotherapyNina N Sanford, Yolande Lievens, Ajay Aggarwal, et al.
Scientific Reports|October 27, 2019
The burden and correlates of multiple cardiometabolic risk factors in a semi-urban population of Nepal: a community-based cross-sectional studyBishal Gyawali, Shiva Raj Mishra, Saruna Ghimire, et al.
Disaster Medicine and Public Health Preparedness|June 18, 2021
Health System Preparedness for COVID-19 and Its Impacts on Frontline Health-Care Workers in Nepal: A Qualitative Study Among Frontline Health-Care Workers and Policy-MakersNipun Shrestha, Shiva Raj Mishra, Saruna Ghimire, et al.
Critical Reviews in Oncology/Hematology|August 12, 2018
Immune-checkpoint inhibitors in non-small cell lung cancer: A tool to improve patients' selectionGiuseppe Luigi Banna, Francesco Passiglia, Francesca Colonese, et al.
Anticancer Research|August 17, 2005
Circulating vascular endothelial growth factor and interferon-gamma-inducible protein-10 levels in pancreatic cancer during chemotherapyGraziella Bellone, Anna Novarino, Isabella Chiappino, et al.
Cancer Chemotherapy and Pharmacology|December 7, 2005
Second-line chemotherapy with weekly paclitaxel and gemcitabine in patients with small-cell lung cancer pretreated with platinum and etoposide: a single institution phase II trialVincenzo Dongiovanni, Lucio Buffoni, Alfredo Berruti, et al.
Oncology Letters|December 2, 2015
Pazopanib monotherapy in a patient with a malignant granular cell tumor originating from the right orbit: A case reportSachi Morita, Mariko Hiramatsu, Mihoko Sugishita, et al.
JAMA Network Open|April 13, 2022
Evaluation of Information Theoretic Network Meta-analysis to Rank First-Line Anticancer Regimens for Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast CancerXuanyi Li, Alicia Beeghly-Fadiel, Suresh K Bhavnani, et al.
BMJ Open|December 13, 2019
Anticancer drug prices and clinical outcomes: a cross-sectional study in ItalyFrancesco Trotta, Flavia Mayer, Francesco Barone-Adesi, et al.
Pageof 37